Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value | |
Location of primary tumor (Rectum) | 1.190 | 0.569-2.486 | 0.644 | |||
Histological type (Poorly, Mucinous) | 1.711 | 0.510-5.746 | 0.385 | 2.305 | 0.602-8.825 | 0.223 |
Detection of unresectable tumor (Metachronous) | 1.069 | 0.442-2.584 | 0.882 | |||
Distant metastasis except peritoneal dissemination (Yes) | 1.188 | 0.280-5.029 | 0.815 | |||
Peritoneal dissemination (Yes) | 0.727 | 0.294-1.797 | 0.490 | 1.198 | 0.279-5.142 | 0.808 |
The number of organs affected by metastasis (≥2) | 0.541 | 0.241-1.125 | 0.137 | 0.273 | 0.083-0.902 | 0.033 |
Pretreatment CEA (>5 ng/ml) | 0.787 | 0.236-2.624 | 0.696 | |||
Pretreatment CA19-9 (>37 U/ml) | 0.862 | 0.403-1.845 | 0.702 | |||
Molecular targeted therapy (Yes) | 0.911 | 0.449-1.848 | 0.797 | |||
Cholinesterase (<235 IU/l) | 0.568 | 0.110-2.941 | 0.500 | |||
Cholesterol (<200 mg/dl) | 0.852 | 0.234-3.102 | 0.809 | |||
NLR (>2.8) | 1.342 | 0.619-2.911 | 0.457 | 1.090 | 0.434-2.737 | 0.855 |
GPS (2) | 1.498 | 0.544-4.123 | 0.434 | 1.758 | 0.489-6.326 | 0.388 |
AGR (>1.25) | 2.527 | 1.152-5.545 | 0.021 | 2.662 | 1.085-6.531 | 0.033 |